Clinical trial
A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema
NCT00479336 · Otsuka Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00479336 |
|---|---|
| Title | A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema |
| Official title | A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema |
| Lead sponsor | Otsuka Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cirrhosis |
| Intervention type | Drug |
| Interventions | OPC-41061 7.5mg, OPC-41061 placebo, OPC-41061 15mg, OPC-41601 30mg |
| Enrollment | 104 |
| Start date | Jun 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | May 28, 2007 |
| Last update posted | Mar 14, 2014 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: